USA - NASDAQ:ACLS - US0545402085 - Common Stock
The current stock price of ACLS is 81.54 USD. In the past month the price decreased by -1.62%. In the past year, price increased by 11.36%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LRCX | LAM RESEARCH CORP | 32.66 | 186.96B | ||
| AMAT | APPLIED MATERIALS INC | 23.99 | 180.05B | ||
| KLAC | KLA CORP | 32.6 | 149.37B | ||
| TER | TERADYNE INC | 54.48 | 27.04B | ||
| ENTG | ENTEGRIS INC | 27.09 | 11.87B | ||
| MKSI | MKS INC | 18.88 | 9.59B | ||
| AMKR | AMKOR TECHNOLOGY INC | 25.34 | 7.83B | ||
| ONTO | ONTO INNOVATION INC | 24.65 | 6.27B | ||
| FORM | FORMFACTOR INC | 45.59 | 3.87B | ||
| ENPH | ENPHASE ENERGY INC | 8.93 | 3.75B | ||
| ACMR | ACM RESEARCH INC-CLASS A | 16.41 | 2.01B | ||
| VECO | VEECO INSTRUMENTS INC | 19.45 | 1.76B |
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. The company is headquartered in Beverly, Massachusetts and currently employs 1,524 full-time employees. The company went IPO on 2000-07-11. The firm is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The firm's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. The company also offers its customers aftermarket service and support.
AXCELIS TECHNOLOGIES INC
108 Cherry Hill Dr
Beverly MASSACHUSETTS 01915 US
CEO: Mary G. Puma
Employees: 1524
Phone: 19787874000
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. The company is headquartered in Beverly, Massachusetts and currently employs 1,524 full-time employees. The company went IPO on 2000-07-11. The firm is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The firm's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. The company also offers its customers aftermarket service and support.
The current stock price of ACLS is 81.54 USD. The price decreased by -1.31% in the last trading session.
ACLS does not pay a dividend.
ACLS has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
AXCELIS TECHNOLOGIES INC (ACLS) operates in the Information Technology sector and the Semiconductors & Semiconductor Equipment industry.
The Revenue of AXCELIS TECHNOLOGIES INC (ACLS) is expected to decline by -22.15% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 5 / 10 to ACLS. When comparing the yearly performance of all stocks, ACLS turns out to be only a medium performer in the overall market: it outperformed 64.29% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to ACLS. Both the health and profitability get an excellent rating, making ACLS a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months ACLS reported a non-GAAP Earnings per Share(EPS) of 4.92. The EPS decreased by -27.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.93% | ||
| ROA | 10.05% | ||
| ROE | 13.32% | ||
| Debt/Equity | 0.04 |
14 analysts have analysed ACLS and the average price target is 107.03 USD. This implies a price increase of 31.26% is expected in the next year compared to the current price of 81.54.
For the next year, analysts expect an EPS growth of -31.47% and a revenue growth -22.15% for ACLS